Professor Zhou is presently the Associate Vice President of Global Medical Development & Associate Dean of International Research, College of Pharmacy, University of South Florida, Tampa (USF), Florida. USF is one of only 25 public research universities nationwide with very high research activity that is also designated as community engaged by the Carnegie Foundation for the Advancement of Teaching. USF is a global research university ranked 34th in federal research expenditures for public universities and is one of the fastest growing in federal funding in the US.
Professor Zhou completed his clinical medical training in China in 1989 and obtained his PhD in 2001 from the School of Medicine, the University of Auckland, New Zealand. Since 2002, Dr. Zhou has served as an Assistant Professor, Senior Lecturer, Associate Professor and Professor for the National University of Singapore, Queensland University of Technology, RMIT University in Australia, and now at USF. Dr. Zhou’s major research interests are systems pharmacology, drug metabolism & drug transport, pharmacokinetics/pharmacometrics, pharmacogenomics, nanomedicine and Chinese medicine.
Professor Zhou has published more than 350 peer-reviewed papers in various pharmacology and medical journals including New England Journal of Medicine, Cancer Research, Journal of Biological Chemistry, Clinical Pharmacology and Therapeutics, and Clinical Cancer Research. He has also published 18 books and book chapters and more than 360 conference abstracts. His work has been cited more than 10,400 times by other colleagues with an H-index of 51. Dr. Zhou has given more than 120 invited seminars/keynote presentations to a variety of academic institutes, government agencies, and high-profile international conferences. He has received more than US$30.0 million grants from various funding bodies and industries.
To date, he has trained 24 PhD students, 12 MSc/Honors students, 14 postdoctoral staff and 45 visiting doctors. Dr. Zhou serves as an editor-in-chief or editor for 16 biomedical journals including Drug Design, Development and Therapy, Drug, Healthcare and Patient Safety, Clinical & Experimental Physiology & Pharmacology, Clinical Pharmacology & Biopharmaceutics, Journal of Pharmacogenomics and Pharmacoproteomics, Drug Metabolism Letters, Journal of Pharmacy and Nutrition Sciences, Current Drug Metabolism, etc. and is the editorial board member of 53 medical and pharmacological journals.
He is a recipient of several national and international awards, a council member of US Pharmacopoeia and advisor of World Health Organization (WHO), a council member or chair of several national and international professional societies, and a visiting/adjunct professor of multiple reputable research universities around the world.